Материалы доступны только для специалистов сферы здравоохранения. Авторизуйтесь или зарегистрируйтесь.
Перикардиты в ревматологии: современные клинико-диагностические аспекты и вопросы терапии
Перикардиты в ревматологии: современные клинико-диагностические аспекты и вопросы терапии
Белов Б.С., Тарасова Г.М. Перикардиты в ревматологии: современные клинико-диагностические аспекты и вопросы терапии. Consilium Medicum. 2020; 22 (1): 26–30. DOI: 10.26442/20751753.2020.1.200060
________________________________________________
Материалы доступны только для специалистов сферы здравоохранения. Авторизуйтесь или зарегистрируйтесь.
Аннотация
Аннотация
Этиология заболеваний перикарда включает две большие группы нозологий – инфекционные и неинфекционные. Среди неинфекционных причин перикардитов важное место занимают иммуновоспалительные ревматические заболевания. В настоящем обзоре изложены клиническая симптоматика и данные дополнительных исследований при основных формах поражения перикарда (перикардит, выпот в полость перикарда, тампонада перикарда и констриктивный перикардит), представлены частота и особенности течения перикардиальной патологии при основных иммуновоспалительных ревматических заболеваниях, включая ревматоидный артрит, системную красную волчанку и системную склеродермию. Отражены основные подходы к терапии разных форм перикардитов.
Ключевые слова: перикардит, тампонада сердца, диагностика, нестероидные противовоспалительные препараты, глюкокортикоиды, колхицин, лечение, рекомендации.
Pericarditis disorders etiology includes two large groups of disorders: infectious and non-infectious. Among non-infectious causes of pericarditis immunoinflammatory rheumatic diseases take an important place. The present review shows clinical presentation and results of additional studies in main forms of pericard damage (pericarditis, pericardial effusion, cardiac tamponage, and constrictive pericarditis). Also, incidence of pericard pathology in major immunoinflammatory rheumatic diseases including rheumatoid arthritis, systemic lupus erythematosus, and systemic scleroderma are presented. Basic approaches to treatment of different forms of pericarditis are presented.
Key words: pericarditis, cardiac tamponage, diagnostics, non-steroidal anti-inflammatory drugs, glucocorticoids, colchicine, treatment, recommendations.
Этиология заболеваний перикарда включает две большие группы нозологий – инфекционные и неинфекционные. Среди неинфекционных причин перикардитов важное место занимают иммуновоспалительные ревматические заболевания. В настоящем обзоре изложены клиническая симптоматика и данные дополнительных исследований при основных формах поражения перикарда (перикардит, выпот в полость перикарда, тампонада перикарда и констриктивный перикардит), представлены частота и особенности течения перикардиальной патологии при основных иммуновоспалительных ревматических заболеваниях, включая ревматоидный артрит, системную красную волчанку и системную склеродермию. Отражены основные подходы к терапии разных форм перикардитов.
Ключевые слова: перикардит, тампонада сердца, диагностика, нестероидные противовоспалительные препараты, глюкокортикоиды, колхицин, лечение, рекомендации.
________________________________________________
Pericarditis disorders etiology includes two large groups of disorders: infectious and non-infectious. Among non-infectious causes of pericarditis immunoinflammatory rheumatic diseases take an important place. The present review shows clinical presentation and results of additional studies in main forms of pericard damage (pericarditis, pericardial effusion, cardiac tamponage, and constrictive pericarditis). Also, incidence of pericard pathology in major immunoinflammatory rheumatic diseases including rheumatoid arthritis, systemic lupus erythematosus, and systemic scleroderma are presented. Basic approaches to treatment of different forms of pericarditis are presented.
Key words: pericarditis, cardiac tamponage, diagnostics, non-steroidal anti-inflammatory drugs, glucocorticoids, colchicine, treatment, recommendations.
Характеристики
| Авторы | Белов Б.С. / Тарасова Г.М. |
Полный текст
Список литературы
1. Imazio M, Cecchi E, Demichelis B et al. Myopericarditis versus viral or idiopathic acute pericarditis. Heart 2008; 94 (4): 498–501.
2. Kytö V, Sipilä J, Rautava P. Clinical profile and influences on outcomes in patients hospitalized for acute pericarditis. Circulation 2014; 130 (18): 1601–6. DOI: 10.1161/CIRCULATIONAHA.114.010376
3. Adler Y, Charron P, Imazio M et al. 2015 ESC Guidelines for the diagnosis and management of pericardial diseases: The Task Force for the Diagnosis and Management of Pericardial Diseases of the European Society of Cardiology (ESC)Endorsed by: The European Association for Cardio-Thoracic
Surgery (EACTS). Eur Heart J 2015; 36 (42): 2921–64. DOI: 10.1093/eurheartj/ehv318
4. McNamara N, Ibrahim A, Satti Z et al. Acute pericarditis: a review of current diagnostic and management guidelines. Future Cardiol 2019; 15 (2): 119–26. DOI: 10.2217/fca-2017-0102
5. Maisch B, Seferovic PM, Ristic AD et al. Task Force on the Diagnosis and Management of Pricardial Diseases of the European Society of Cardiology. Guidelines on the diagnosis and management of pericardial diseases executive summary; The Task force on the diagnosis and management of pericardial diseases of the European society of cardiology. Eur Heart J 2004; 25 (7): 587–610. DOI:10.1016/j.ehj.2004.02.002
6. Gewitz MH, Baltimore RS, Tani LY et al. Revision of the Jones Criteria for the diagnosis of acute rheumatic fever in the era of Doppler echocardiography: a scientific statement from the American Heart Association. Circulation 2015; 131 (20): 1806–18. DOI: 10.1161/CIR.0000000000000205
7. Асадов А.Г. Физическая работоспособность больных ревмокардитом. Автореф. дис. … канд. мед. наук. М., 1984.
[Asadov A.G. Fizicheskaya rabotosposobnost' bol'nyh revmokarditom. Avtoref. dis. … kand. med. nauk. Moscow, 1984 (in Russian).]
8. Джузенова Б.С., Котельникова Г.П., Михайлова И.Н., Насонова В.А. Острый ревмокардит у молодых мужчин. Терапевтический архив. 1992; 4: 58–62.
[Dzhuzenova B.S., Kotel'nikova G.P., Mihajlova I.N., Nasonova V.A. Ostryj revmokardit u molodyh muzhchin. Therapeutic Archive. 1992; 4: 58–62 (in Russian).]
9. Медынцева Л.Г. Физическая работоспособность больных ревматизмом детей на этапе диспансеризации. Автореф. дис. … канд. мед. наук. М., 1990.
[Medynceva L.G. Fizicheskaya rabotosposobnost' bol'nyh revmatizmom detej na etape dispanserizacii. Avtoref. dis. … kand. med. nauk. Moscow, 1990 (in Russian).]
10. Сигидин Я.А., Гусева Н.Г., Иванова М.М. Диффузные болезни соединительной ткани (системные ревматические заболевания): руководство для врачей. М.: Медицина, 2004.
[Sigidin Ya.A., Guseva N.G., Ivanova M.M. Diffuse connective tissue diseases (systemic rheumatic diseases): a guide for doctors. Moscow: Medicine, 2004 (in Russian).]
11. Guedes C, Dianchi-Fior P, Cormier B et al. Cardiac manifestations of rheumatoid arthritis: A case-control transesophageal echocardiography study in 30 patients. Arthritis Care Res 2001; 45 (2): 129–35.
12. McRorie ER, Wright RA, Errington ML, Luoqmani RA. Rheumatoid constrictive pericarditis. Br J Rheumatol 1997; 36: 100–3.
13. El Hasbani G, Masri BK, Rebeiz AG, Uthman I. Recurrent Pericarditis as an Initial Presentation of Rheumatoid Arthritis. Am J Med 2020; 133 (2): e50–e51. DOI: 10.1016/j.amjmed.2019.07.038
14. Lutman C, Finocchiaro G, Abate E et al. Purulent pericarditis in rheumatoid arthritis treated with rituximab and methotrexate. J Cardiovasc Med (Hagerstown) 2014; 15 (12): 880–2. DOI:10.2459/JCM.0000000000000160
15. Kahl LE. The spectrum of pericardial tamponade in systemic lupus erythematosus. Report of ten patients. Arthritis Rheum 1992; 35 (11): 1343–9.
16. Moder KG, Miller TD, Tazelaar HD. Cardiac involvement in systemic lupus erythematosus. Mayo Clin Proc 1999; 74 (3): 275–84.
17. Dein E, Douglas H, Petri M et al. Pericarditis in Lupus. Cureus 2019; 11 (3): e4166. DOI: 10.7759/cureus. 4166
18. Butt SA, Jeppesen JL, Torp-Pedersen C et al. Cardiovascular Manifestations of Systemic Sclerosis: A Danish Nationwide Cohort Study. J Am Heart Assoc 2019; 8 (17): e013405. DOI:10.1161/JAHA.119.013405
19. Bissell LA, Anderson M, Burgess M et al. Consensus best practice pathway of the UK Systemic Sclerosis Study group: management of cardiac disease in systemic sclerosis. Rheumatology (Oxford)
2017; 56 (6): 912–21. DOI: 10.1093/rheumatology/kew488/
20. Pagnoux C, Guillevin L. Cardiac involvemenrt in small and medium-sized vessel vasculitides. Lupus 2005; 14: 718–22.
21. Efthimiou P, Paik PK, Bielory L. Diagnosis and management of adult onset Still's disease. Ann Rheum Dis 2006; 65 (5): 564–72.
22. Drout MH, Hachulla E, Houvenagel E et al. [Cardiac complications in adult onset Still disease:from periarditis to tamponade as manifestations.] Rev Med Interne 1994; 15 (11): 740–3.
23. Gyongyosi M, Pokorny G, Jambrik Z et al. Cardiac manifestations in primary Sjogren syndrome. Ann Rheum Dis 1996; 55 (7): 450–4.
24. Hu QY, Zeng T, Sun CY et al. Clinical features and current treatments of adult-onset Still's disease: a multicentre survey of 517 patients in China. Clin Exp Rheumatol 2019; 37 (Suppl. 121; 6): 52–7.
25. Hintenberger R, Falkinger A, Danninger K, Pieringer H. Cardiovascular disease in patients with autoinflammatory syndromes. Rheumatol Int 2018; 38 (1): 37–50. DOI: 10.1007/s00296-017-3854-7
26. Dall'Ara F, Frassi M, Tincani A, Airò P. A retrospective study of patients with adult-onset Still's disease: is pericarditis a possible predictor for biological disease-modifying anti-rheumatic drugs need? Clin Rheumatol 2016; 35 (8): 2117–23. DOI: 10.1007/s10067-015-3164-y
27. Misra DP, Shenoy SN. Cardiac involvement in primary systemic vasculitis and potential drug therapies to reduce cardiovascular risk. Rheumatol Int 2017; 37 (1): 151–67. DOI: 10.1007/s00296-016-3435-1
28. Kechida M, Salah S, Kahloun R et al. Cardiac and vascular complications of Behçet disease in the Tunisian context: clinical characteristics and predictive factors. Adv Rheumatol 2018; 58 (1): 32. DOI: 10.1186/s42358-018-0032-x
29. Tiosano S, Adler Y, Azrielant S et al. Pericarditis among giant cell arteritis patients: From myth to reality. Clin Cardiol 2018; 41 (5): 623–7. DOI: 10.1002/clc.22927
30. Imazio M, Spodick DH, Brucato A et al. Controversial issues in the management of pericardial diseases.
Circulation 2010; 121 (7): 916–28. DOI: 10.1161/CIRCULATIONAHA.108.844753
31. Brucato A, Imazio M, Gattorno M et al. Effect of Anakinra on Recurrent Pericarditis Among Patients With Colchicine Resistance and Corticosteroid Dependence: The AIRTRIP Randomized Clinical Trial. JAMA 2016; 316 (18): 1906–12. DOI: 10.1001/jama.2016.15826
32. Wiysonge CS, Ntsekhe M, Thabane L et al. Interventions for treating tuberculous pericarditis. Cochrane Database Sys Rev 2017; 9: CD000526. DOI: 10.1002/14651858.CD000526.pub2
33. Choi MS, Jeong DS, Oh JK et al. Long-term results of radical pericardiectomy for constrictive pericarditis in Korean population. J Cardiothorac Surg 2019; 14 (1): 32. DOI: 10.1186/s13019-019-0845-7
2. Kytö V, Sipilä J, Rautava P. Clinical profile and influences on outcomes in patients hospitalized for acute pericarditis. Circulation 2014; 130 (18): 1601–6. DOI: 10.1161/CIRCULATIONAHA.114.010376
3. Adler Y, Charron P, Imazio M et al. 2015 ESC Guidelines for the diagnosis and management of pericardial diseases: The Task Force for the Diagnosis and Management of Pericardial Diseases of the European Society of Cardiology (ESC)Endorsed by: The European Association for Cardio-Thoracic
Surgery (EACTS). Eur Heart J 2015; 36 (42): 2921–64. DOI: 10.1093/eurheartj/ehv318
4. McNamara N, Ibrahim A, Satti Z et al. Acute pericarditis: a review of current diagnostic and management guidelines. Future Cardiol 2019; 15 (2): 119–26. DOI: 10.2217/fca-2017-0102
5. Maisch B, Seferovic PM, Ristic AD et al. Task Force on the Diagnosis and Management of Pricardial Diseases of the European Society of Cardiology. Guidelines on the diagnosis and management of pericardial diseases executive summary; The Task force on the diagnosis and management of pericardial diseases of the European society of cardiology. Eur Heart J 2004; 25 (7): 587–610. DOI:10.1016/j.ehj.2004.02.002
6. Gewitz MH, Baltimore RS, Tani LY et al. Revision of the Jones Criteria for the diagnosis of acute rheumatic fever in the era of Doppler echocardiography: a scientific statement from the American Heart Association. Circulation 2015; 131 (20): 1806–18. DOI: 10.1161/CIR.0000000000000205
7. Asadov A.G. Fizicheskaya rabotosposobnost' bol'nyh revmokarditom. Avtoref. dis. … kand. med. nauk. Moscow, 1984 (in Russian).
8. Dzhuzenova B.S., Kotel'nikova G.P., Mihajlova I.N., Nasonova V.A. Ostryj revmokardit u molodyh muzhchin. Therapeutic Archive. 1992; 4: 58–62 (in Russian).
9. Medynceva L.G. Fizicheskaya rabotosposobnost' bol'nyh revmatizmom detej na etape dispanserizacii. Avtoref. dis. … kand. med. nauk. Moscow, 1990 (in Russian).
10. Sigidin Ya.A., Guseva N.G., Ivanova M.M. Diffuse connective tissue diseases (systemic rheumatic diseases): a guide for doctors. Moscow: Medicine, 2004 (in Russian).
11. Guedes C, Dianchi-Fior P, Cormier B et al. Cardiac manifestations of rheumatoid arthritis: A case-control transesophageal echocardiography study in 30 patients. Arthritis Care Res 2001; 45 (2): 129–35.
12. McRorie ER, Wright RA, Errington ML, Luoqmani RA. Rheumatoid constrictive pericarditis. Br J Rheumatol 1997; 36: 100–3.
13. El Hasbani G, Masri BK, Rebeiz AG, Uthman I. Recurrent Pericarditis as an Initial Presentation of Rheumatoid Arthritis. Am J Med 2020; 133 (2): e50–e51. DOI: 10.1016/j.amjmed.2019.07.038
14. Lutman C, Finocchiaro G, Abate E et al. Purulent pericarditis in rheumatoid arthritis treated with rituximab and methotrexate. J Cardiovasc Med (Hagerstown) 2014; 15 (12): 880–2. DOI:10.2459/JCM.0000000000000160
15. Kahl LE. The spectrum of pericardial tamponade in systemic lupus erythematosus. Report of ten patients. Arthritis Rheum 1992; 35 (11): 1343–9.
16. Moder KG, Miller TD, Tazelaar HD. Cardiac involvement in systemic lupus erythematosus. Mayo Clin Proc 1999; 74 (3): 275–84.
17. Dein E, Douglas H, Petri M et al. Pericarditis in Lupus. Cureus 2019; 11 (3): e4166. DOI: 10.7759/cureus. 4166
18. Butt SA, Jeppesen JL, Torp-Pedersen C et al. Cardiovascular Manifestations of Systemic Sclerosis: A Danish Nationwide Cohort Study. J Am Heart Assoc 2019; 8 (17): e013405. DOI:10.1161/JAHA.119.013405
19. Bissell LA, Anderson M, Burgess M et al. Consensus best practice pathway of the UK Systemic Sclerosis Study group: management of cardiac disease in systemic sclerosis. Rheumatology (Oxford)
2017; 56 (6): 912–21. DOI: 10.1093/rheumatology/kew488/
20. Pagnoux C, Guillevin L. Cardiac involvemenrt in small and medium-sized vessel vasculitides. Lupus 2005; 14: 718–22.
21. Efthimiou P, Paik PK, Bielory L. Diagnosis and management of adult onset Still's disease. Ann Rheum Dis 2006; 65 (5): 564–72.
22. Drout MH, Hachulla E, Houvenagel E et al. [Cardiac complications in adult onset Still disease:from periarditis to tamponade as manifestations.] Rev Med Interne 1994; 15 (11): 740–3.
23. Gyongyosi M, Pokorny G, Jambrik Z et al. Cardiac manifestations in primary Sjogren syndrome. Ann Rheum Dis 1996; 55 (7): 450–4.
24. Hu QY, Zeng T, Sun CY et al. Clinical features and current treatments of adult-onset Still's disease: a multicentre survey of 517 patients in China. Clin Exp Rheumatol 2019; 37 (Suppl. 121; 6): 52–7.
25. Hintenberger R, Falkinger A, Danninger K, Pieringer H. Cardiovascular disease in patients with autoinflammatory syndromes. Rheumatol Int 2018; 38 (1): 37–50. DOI: 10.1007/s00296-017-3854-7
26. Dall'Ara F, Frassi M, Tincani A, Airò P. A retrospective study of patients with adult-onset Still's disease: is pericarditis a possible predictor for biological disease-modifying anti-rheumatic drugs need? Clin Rheumatol 2016; 35 (8): 2117–23. DOI: 10.1007/s10067-015-3164-y
27. Misra DP, Shenoy SN. Cardiac involvement in primary systemic vasculitis and potential drug therapies to reduce cardiovascular risk. Rheumatol Int 2017; 37 (1): 151–67. DOI: 10.1007/s00296-016-3435-1
28. Kechida M, Salah S, Kahloun R et al. Cardiac and vascular complications of Behçet disease in the Tunisian context: clinical characteristics and predictive factors. Adv Rheumatol 2018; 58 (1): 32. DOI: 10.1186/s42358-018-0032-x
29. Tiosano S, Adler Y, Azrielant S et al. Pericarditis among giant cell arteritis patients: From myth to reality. Clin Cardiol 2018; 41 (5): 623–7. DOI: 10.1002/clc.22927
30. Imazio M, Spodick DH, Brucato A et al. Controversial issues in the management of pericardial diseases.
Circulation 2010; 121 (7): 916–28. DOI: 10.1161/CIRCULATIONAHA.108.844753
31. Brucato A, Imazio M, Gattorno M et al. Effect of Anakinra on Recurrent Pericarditis Among Patients With Colchicine Resistance and Corticosteroid Dependence: The AIRTRIP Randomized Clinical Trial. JAMA 2016; 316 (18): 1906–12. DOI: 10.1001/jama.2016.15826
32. Wiysonge CS, Ntsekhe M, Thabane L et al. Interventions for treating tuberculous pericarditis. Cochrane Database Sys Rev 2017; 9: CD000526. DOI: 10.1002/14651858.CD000526.pub2
33. Choi MS, Jeong DS, Oh JK et al. Long-term results of radical pericardiectomy for constrictive pericarditis in Korean population. J Cardiothorac Surg 2019; 14 (1): 32. DOI: 10.1186/s13019-019-0845-7
2. Kytö V, Sipilä J, Rautava P. Clinical profile and influences on outcomes in patients hospitalized for acute pericarditis. Circulation 2014; 130 (18): 1601–6. DOI: 10.1161/CIRCULATIONAHA.114.010376
3. Adler Y, Charron P, Imazio M et al. 2015 ESC Guidelines for the diagnosis and management of pericardial diseases: The Task Force for the Diagnosis and Management of Pericardial Diseases of the European Society of Cardiology (ESC)Endorsed by: The European Association for Cardio-Thoracic
Surgery (EACTS). Eur Heart J 2015; 36 (42): 2921–64. DOI: 10.1093/eurheartj/ehv318
4. McNamara N, Ibrahim A, Satti Z et al. Acute pericarditis: a review of current diagnostic and management guidelines. Future Cardiol 2019; 15 (2): 119–26. DOI: 10.2217/fca-2017-0102
5. Maisch B, Seferovic PM, Ristic AD et al. Task Force on the Diagnosis and Management of Pricardial Diseases of the European Society of Cardiology. Guidelines on the diagnosis and management of pericardial diseases executive summary; The Task force on the diagnosis and management of pericardial diseases of the European society of cardiology. Eur Heart J 2004; 25 (7): 587–610. DOI:10.1016/j.ehj.2004.02.002
6. Gewitz MH, Baltimore RS, Tani LY et al. Revision of the Jones Criteria for the diagnosis of acute rheumatic fever in the era of Doppler echocardiography: a scientific statement from the American Heart Association. Circulation 2015; 131 (20): 1806–18. DOI: 10.1161/CIR.0000000000000205
7. Асадов А.Г. Физическая работоспособность больных ревмокардитом. Автореф. дис. … канд. мед. наук. М., 1984.
[Asadov A.G. Fizicheskaya rabotosposobnost' bol'nyh revmokarditom. Avtoref. dis. … kand. med. nauk. Moscow, 1984 (in Russian).]
8. Джузенова Б.С., Котельникова Г.П., Михайлова И.Н., Насонова В.А. Острый ревмокардит у молодых мужчин. Терапевтический архив. 1992; 4: 58–62.
[Dzhuzenova B.S., Kotel'nikova G.P., Mihajlova I.N., Nasonova V.A. Ostryj revmokardit u molodyh muzhchin. Therapeutic Archive. 1992; 4: 58–62 (in Russian).]
9. Медынцева Л.Г. Физическая работоспособность больных ревматизмом детей на этапе диспансеризации. Автореф. дис. … канд. мед. наук. М., 1990.
[Medynceva L.G. Fizicheskaya rabotosposobnost' bol'nyh revmatizmom detej na etape dispanserizacii. Avtoref. dis. … kand. med. nauk. Moscow, 1990 (in Russian).]
10. Сигидин Я.А., Гусева Н.Г., Иванова М.М. Диффузные болезни соединительной ткани (системные ревматические заболевания): руководство для врачей. М.: Медицина, 2004.
[Sigidin Ya.A., Guseva N.G., Ivanova M.M. Diffuse connective tissue diseases (systemic rheumatic diseases): a guide for doctors. Moscow: Medicine, 2004 (in Russian).]
11. Guedes C, Dianchi-Fior P, Cormier B et al. Cardiac manifestations of rheumatoid arthritis: A case-control transesophageal echocardiography study in 30 patients. Arthritis Care Res 2001; 45 (2): 129–35.
12. McRorie ER, Wright RA, Errington ML, Luoqmani RA. Rheumatoid constrictive pericarditis. Br J Rheumatol 1997; 36: 100–3.
13. El Hasbani G, Masri BK, Rebeiz AG, Uthman I. Recurrent Pericarditis as an Initial Presentation of Rheumatoid Arthritis. Am J Med 2020; 133 (2): e50–e51. DOI: 10.1016/j.amjmed.2019.07.038
14. Lutman C, Finocchiaro G, Abate E et al. Purulent pericarditis in rheumatoid arthritis treated with rituximab and methotrexate. J Cardiovasc Med (Hagerstown) 2014; 15 (12): 880–2. DOI:10.2459/JCM.0000000000000160
15. Kahl LE. The spectrum of pericardial tamponade in systemic lupus erythematosus. Report of ten patients. Arthritis Rheum 1992; 35 (11): 1343–9.
16. Moder KG, Miller TD, Tazelaar HD. Cardiac involvement in systemic lupus erythematosus. Mayo Clin Proc 1999; 74 (3): 275–84.
17. Dein E, Douglas H, Petri M et al. Pericarditis in Lupus. Cureus 2019; 11 (3): e4166. DOI: 10.7759/cureus. 4166
18. Butt SA, Jeppesen JL, Torp-Pedersen C et al. Cardiovascular Manifestations of Systemic Sclerosis: A Danish Nationwide Cohort Study. J Am Heart Assoc 2019; 8 (17): e013405. DOI:10.1161/JAHA.119.013405
19. Bissell LA, Anderson M, Burgess M et al. Consensus best practice pathway of the UK Systemic Sclerosis Study group: management of cardiac disease in systemic sclerosis. Rheumatology (Oxford)
2017; 56 (6): 912–21. DOI: 10.1093/rheumatology/kew488/
20. Pagnoux C, Guillevin L. Cardiac involvemenrt in small and medium-sized vessel vasculitides. Lupus 2005; 14: 718–22.
21. Efthimiou P, Paik PK, Bielory L. Diagnosis and management of adult onset Still's disease. Ann Rheum Dis 2006; 65 (5): 564–72.
22. Drout MH, Hachulla E, Houvenagel E et al. [Cardiac complications in adult onset Still disease:from periarditis to tamponade as manifestations.] Rev Med Interne 1994; 15 (11): 740–3.
23. Gyongyosi M, Pokorny G, Jambrik Z et al. Cardiac manifestations in primary Sjogren syndrome. Ann Rheum Dis 1996; 55 (7): 450–4.
24. Hu QY, Zeng T, Sun CY et al. Clinical features and current treatments of adult-onset Still's disease: a multicentre survey of 517 patients in China. Clin Exp Rheumatol 2019; 37 (Suppl. 121; 6): 52–7.
25. Hintenberger R, Falkinger A, Danninger K, Pieringer H. Cardiovascular disease in patients with autoinflammatory syndromes. Rheumatol Int 2018; 38 (1): 37–50. DOI: 10.1007/s00296-017-3854-7
26. Dall'Ara F, Frassi M, Tincani A, Airò P. A retrospective study of patients with adult-onset Still's disease: is pericarditis a possible predictor for biological disease-modifying anti-rheumatic drugs need? Clin Rheumatol 2016; 35 (8): 2117–23. DOI: 10.1007/s10067-015-3164-y
27. Misra DP, Shenoy SN. Cardiac involvement in primary systemic vasculitis and potential drug therapies to reduce cardiovascular risk. Rheumatol Int 2017; 37 (1): 151–67. DOI: 10.1007/s00296-016-3435-1
28. Kechida M, Salah S, Kahloun R et al. Cardiac and vascular complications of Behçet disease in the Tunisian context: clinical characteristics and predictive factors. Adv Rheumatol 2018; 58 (1): 32. DOI: 10.1186/s42358-018-0032-x
29. Tiosano S, Adler Y, Azrielant S et al. Pericarditis among giant cell arteritis patients: From myth to reality. Clin Cardiol 2018; 41 (5): 623–7. DOI: 10.1002/clc.22927
30. Imazio M, Spodick DH, Brucato A et al. Controversial issues in the management of pericardial diseases.
Circulation 2010; 121 (7): 916–28. DOI: 10.1161/CIRCULATIONAHA.108.844753
31. Brucato A, Imazio M, Gattorno M et al. Effect of Anakinra on Recurrent Pericarditis Among Patients With Colchicine Resistance and Corticosteroid Dependence: The AIRTRIP Randomized Clinical Trial. JAMA 2016; 316 (18): 1906–12. DOI: 10.1001/jama.2016.15826
32. Wiysonge CS, Ntsekhe M, Thabane L et al. Interventions for treating tuberculous pericarditis. Cochrane Database Sys Rev 2017; 9: CD000526. DOI: 10.1002/14651858.CD000526.pub2
33. Choi MS, Jeong DS, Oh JK et al. Long-term results of radical pericardiectomy for constrictive pericarditis in Korean population. J Cardiothorac Surg 2019; 14 (1): 32. DOI: 10.1186/s13019-019-0845-7
________________________________________________
2. Kytö V, Sipilä J, Rautava P. Clinical profile and influences on outcomes in patients hospitalized for acute pericarditis. Circulation 2014; 130 (18): 1601–6. DOI: 10.1161/CIRCULATIONAHA.114.010376
3. Adler Y, Charron P, Imazio M et al. 2015 ESC Guidelines for the diagnosis and management of pericardial diseases: The Task Force for the Diagnosis and Management of Pericardial Diseases of the European Society of Cardiology (ESC)Endorsed by: The European Association for Cardio-Thoracic
Surgery (EACTS). Eur Heart J 2015; 36 (42): 2921–64. DOI: 10.1093/eurheartj/ehv318
4. McNamara N, Ibrahim A, Satti Z et al. Acute pericarditis: a review of current diagnostic and management guidelines. Future Cardiol 2019; 15 (2): 119–26. DOI: 10.2217/fca-2017-0102
5. Maisch B, Seferovic PM, Ristic AD et al. Task Force on the Diagnosis and Management of Pricardial Diseases of the European Society of Cardiology. Guidelines on the diagnosis and management of pericardial diseases executive summary; The Task force on the diagnosis and management of pericardial diseases of the European society of cardiology. Eur Heart J 2004; 25 (7): 587–610. DOI:10.1016/j.ehj.2004.02.002
6. Gewitz MH, Baltimore RS, Tani LY et al. Revision of the Jones Criteria for the diagnosis of acute rheumatic fever in the era of Doppler echocardiography: a scientific statement from the American Heart Association. Circulation 2015; 131 (20): 1806–18. DOI: 10.1161/CIR.0000000000000205
7. Asadov A.G. Fizicheskaya rabotosposobnost' bol'nyh revmokarditom. Avtoref. dis. … kand. med. nauk. Moscow, 1984 (in Russian).
8. Dzhuzenova B.S., Kotel'nikova G.P., Mihajlova I.N., Nasonova V.A. Ostryj revmokardit u molodyh muzhchin. Therapeutic Archive. 1992; 4: 58–62 (in Russian).
9. Medynceva L.G. Fizicheskaya rabotosposobnost' bol'nyh revmatizmom detej na etape dispanserizacii. Avtoref. dis. … kand. med. nauk. Moscow, 1990 (in Russian).
10. Sigidin Ya.A., Guseva N.G., Ivanova M.M. Diffuse connective tissue diseases (systemic rheumatic diseases): a guide for doctors. Moscow: Medicine, 2004 (in Russian).
11. Guedes C, Dianchi-Fior P, Cormier B et al. Cardiac manifestations of rheumatoid arthritis: A case-control transesophageal echocardiography study in 30 patients. Arthritis Care Res 2001; 45 (2): 129–35.
12. McRorie ER, Wright RA, Errington ML, Luoqmani RA. Rheumatoid constrictive pericarditis. Br J Rheumatol 1997; 36: 100–3.
13. El Hasbani G, Masri BK, Rebeiz AG, Uthman I. Recurrent Pericarditis as an Initial Presentation of Rheumatoid Arthritis. Am J Med 2020; 133 (2): e50–e51. DOI: 10.1016/j.amjmed.2019.07.038
14. Lutman C, Finocchiaro G, Abate E et al. Purulent pericarditis in rheumatoid arthritis treated with rituximab and methotrexate. J Cardiovasc Med (Hagerstown) 2014; 15 (12): 880–2. DOI:10.2459/JCM.0000000000000160
15. Kahl LE. The spectrum of pericardial tamponade in systemic lupus erythematosus. Report of ten patients. Arthritis Rheum 1992; 35 (11): 1343–9.
16. Moder KG, Miller TD, Tazelaar HD. Cardiac involvement in systemic lupus erythematosus. Mayo Clin Proc 1999; 74 (3): 275–84.
17. Dein E, Douglas H, Petri M et al. Pericarditis in Lupus. Cureus 2019; 11 (3): e4166. DOI: 10.7759/cureus. 4166
18. Butt SA, Jeppesen JL, Torp-Pedersen C et al. Cardiovascular Manifestations of Systemic Sclerosis: A Danish Nationwide Cohort Study. J Am Heart Assoc 2019; 8 (17): e013405. DOI:10.1161/JAHA.119.013405
19. Bissell LA, Anderson M, Burgess M et al. Consensus best practice pathway of the UK Systemic Sclerosis Study group: management of cardiac disease in systemic sclerosis. Rheumatology (Oxford)
2017; 56 (6): 912–21. DOI: 10.1093/rheumatology/kew488/
20. Pagnoux C, Guillevin L. Cardiac involvemenrt in small and medium-sized vessel vasculitides. Lupus 2005; 14: 718–22.
21. Efthimiou P, Paik PK, Bielory L. Diagnosis and management of adult onset Still's disease. Ann Rheum Dis 2006; 65 (5): 564–72.
22. Drout MH, Hachulla E, Houvenagel E et al. [Cardiac complications in adult onset Still disease:from periarditis to tamponade as manifestations.] Rev Med Interne 1994; 15 (11): 740–3.
23. Gyongyosi M, Pokorny G, Jambrik Z et al. Cardiac manifestations in primary Sjogren syndrome. Ann Rheum Dis 1996; 55 (7): 450–4.
24. Hu QY, Zeng T, Sun CY et al. Clinical features and current treatments of adult-onset Still's disease: a multicentre survey of 517 patients in China. Clin Exp Rheumatol 2019; 37 (Suppl. 121; 6): 52–7.
25. Hintenberger R, Falkinger A, Danninger K, Pieringer H. Cardiovascular disease in patients with autoinflammatory syndromes. Rheumatol Int 2018; 38 (1): 37–50. DOI: 10.1007/s00296-017-3854-7
26. Dall'Ara F, Frassi M, Tincani A, Airò P. A retrospective study of patients with adult-onset Still's disease: is pericarditis a possible predictor for biological disease-modifying anti-rheumatic drugs need? Clin Rheumatol 2016; 35 (8): 2117–23. DOI: 10.1007/s10067-015-3164-y
27. Misra DP, Shenoy SN. Cardiac involvement in primary systemic vasculitis and potential drug therapies to reduce cardiovascular risk. Rheumatol Int 2017; 37 (1): 151–67. DOI: 10.1007/s00296-016-3435-1
28. Kechida M, Salah S, Kahloun R et al. Cardiac and vascular complications of Behçet disease in the Tunisian context: clinical characteristics and predictive factors. Adv Rheumatol 2018; 58 (1): 32. DOI: 10.1186/s42358-018-0032-x
29. Tiosano S, Adler Y, Azrielant S et al. Pericarditis among giant cell arteritis patients: From myth to reality. Clin Cardiol 2018; 41 (5): 623–7. DOI: 10.1002/clc.22927
30. Imazio M, Spodick DH, Brucato A et al. Controversial issues in the management of pericardial diseases.
Circulation 2010; 121 (7): 916–28. DOI: 10.1161/CIRCULATIONAHA.108.844753
31. Brucato A, Imazio M, Gattorno M et al. Effect of Anakinra on Recurrent Pericarditis Among Patients With Colchicine Resistance and Corticosteroid Dependence: The AIRTRIP Randomized Clinical Trial. JAMA 2016; 316 (18): 1906–12. DOI: 10.1001/jama.2016.15826
32. Wiysonge CS, Ntsekhe M, Thabane L et al. Interventions for treating tuberculous pericarditis. Cochrane Database Sys Rev 2017; 9: CD000526. DOI: 10.1002/14651858.CD000526.pub2
33. Choi MS, Jeong DS, Oh JK et al. Long-term results of radical pericardiectomy for constrictive pericarditis in Korean population. J Cardiothorac Surg 2019; 14 (1): 32. DOI: 10.1186/s13019-019-0845-7
Авторы
Б.С. Белов*, Г.М. Тарасова
ФГБНУ «Научно-исследовательский институт ревматологии им. В.А. Насоновой», Москва, Россия
*belovbor@yandex.ru
Nasonova Research Institute of Rheumatology, Moscow, Russia
*belovbor@yandex.ru
ФГБНУ «Научно-исследовательский институт ревматологии им. В.А. Насоновой», Москва, Россия
*belovbor@yandex.ru
________________________________________________
Nasonova Research Institute of Rheumatology, Moscow, Russia
*belovbor@yandex.ru
Цель портала OmniDoctor – предоставление профессиональной информации врачам, провизорам и фармацевтам.